ATE488240T1 - Mittel zur behanldung von krankheiten zur aufbringung auf das auge - Google Patents
Mittel zur behanldung von krankheiten zur aufbringung auf das augeInfo
- Publication number
- ATE488240T1 ATE488240T1 AT04727990T AT04727990T ATE488240T1 AT E488240 T1 ATE488240 T1 AT E488240T1 AT 04727990 T AT04727990 T AT 04727990T AT 04727990 T AT04727990 T AT 04727990T AT E488240 T1 ATE488240 T1 AT E488240T1
- Authority
- AT
- Austria
- Prior art keywords
- estrogen
- eye
- agents
- application
- treating diseases
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/10—Ophthalmic agents for accommodation disorders, e.g. myopia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/34—Gestagens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003114969 | 2003-04-18 | ||
JP2003132910 | 2003-05-12 | ||
JP2003329165 | 2003-09-19 | ||
JP2003354135 | 2003-10-14 | ||
PCT/JP2004/004709 WO2004093882A1 (ja) | 2003-04-18 | 2004-03-31 | 眼に適用する疾患治療剤 |
PCT/JP2004/005479 WO2004091630A1 (ja) | 2003-04-18 | 2004-04-16 | 眼に適用する疾患治療剤 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE488240T1 true ATE488240T1 (de) | 2010-12-15 |
Family
ID=33304160
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT04727990T ATE488240T1 (de) | 2003-04-18 | 2004-04-16 | Mittel zur behanldung von krankheiten zur aufbringung auf das auge |
Country Status (7)
Country | Link |
---|---|
EP (6) | EP1621199B8 (de) |
JP (2) | JP4564920B2 (de) |
AT (1) | ATE488240T1 (de) |
AU (1) | AU2004229291A1 (de) |
CA (1) | CA2527175A1 (de) |
DE (1) | DE602004030103D1 (de) |
WO (1) | WO2004091630A1 (de) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1621199B8 (de) * | 2003-04-18 | 2011-01-19 | Advanced Medicine Research Institute | Mittel zur behanldung von krankheiten zur aufbringung auf das auge |
EP2540696B1 (de) | 2005-02-24 | 2020-01-01 | Diffusion Pharmaceuticals LLC | Trans-Karotinoide, deren Formulierung und Verwendung |
JP2008542296A (ja) * | 2005-05-25 | 2008-11-27 | サートリス ファーマシューティカルズ, インコーポレイテッド | サーチュイン活性化剤による眼障害の処置 |
US8940764B2 (en) | 2005-05-26 | 2015-01-27 | Aldexa Therapeutics, Inc. | Compositions and methods of treating retinal disease |
US8987241B2 (en) * | 2009-06-19 | 2015-03-24 | Altos Vision Limited | Time-release and micro-dose formulations for topical application of estrogen and estrogen analogs or other estrogen receptor modulators in the treatment of dry eye syndrome, and methods of preparation and application |
CA2765697C (en) | 2009-06-22 | 2019-11-12 | Diffusion Pharmaceuticals Llc | Diffusion enhancing compounds and their use alone or with thrombolytics |
CA2782015C (en) * | 2009-12-11 | 2020-08-25 | Neuron Systems, Inc. | Topical ophthalmic compositions and methods for the treatment of macular degeneration |
AU2011262361A1 (en) | 2010-06-02 | 2013-01-10 | Diffusion Pharmaceuticals Llc | Oral formulations of bipolar trans carotenoids |
AU2013361314A1 (en) | 2012-12-20 | 2015-07-02 | Aldeyra Therapeutics, Inc. | Peri-carbinols |
CN111135171B (zh) | 2013-01-23 | 2023-09-08 | 奥尔德拉医疗公司 | 与毒性醛相关的疾病和治疗 |
AU2014209585A1 (en) | 2013-01-25 | 2015-07-23 | Aldeyra Therapeutics, Inc. | Novel traps in the treatment of macular degeneration |
WO2017035077A1 (en) | 2015-08-21 | 2017-03-02 | Aldeyra Therapeutics, Inc. | Deuterated compounds and uses thereof |
CA3016759A1 (en) | 2016-02-28 | 2017-08-31 | Aldeyra Therapeutics, Inc. | Treatment of allergic eye conditions with cyclodextrins |
CN115089569A (zh) | 2016-03-24 | 2022-09-23 | 扩散药品有限公司 | 双极性反式类胡萝卜素连同化疗和放射治疗在治疗癌症中的用途 |
CA3022665A1 (en) | 2016-05-09 | 2017-11-16 | Aldeyra Therapeutics, Inc. | Combination treatment of ocular inflammatory disorders and diseases |
CA3054811A1 (en) | 2017-03-16 | 2018-09-20 | Aldeyra Therapeutics, Inc. | Polymorphic compounds and uses thereof |
JP6923917B2 (ja) * | 2017-09-21 | 2021-08-25 | 国立大学法人福井大学 | 白内障の予防剤および治療剤、ならびに、これらを製造するためのhif経路阻害剤の使用 |
CN111356451A (zh) | 2017-10-10 | 2020-06-30 | 奥尔德拉医疗公司 | 炎性病症的治疗 |
CN112714762A (zh) | 2018-08-06 | 2021-04-27 | 奥尔德拉医疗公司 | 多晶型化合物及其用途 |
US11197821B2 (en) | 2018-09-25 | 2021-12-14 | Aldeyra Therapeutics, Inc. | Formulations for treatment of dry eye disease |
US11786518B2 (en) | 2019-03-26 | 2023-10-17 | Aldeyra Therapeutics, Inc. | Ophthalmic formulations and uses thereof |
WO2022255282A1 (ja) * | 2021-05-31 | 2022-12-08 | 国立大学法人大阪大学 | 動体視力向上用組成物 |
CN115105512A (zh) * | 2022-08-29 | 2022-09-27 | 中山大学中山眼科中心 | 脱氢表雄酮在制备预防、治疗眼部近视的药物中的用途及其剂型和制备方法 |
Family Cites Families (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4383992A (en) * | 1982-02-08 | 1983-05-17 | Lipari John M | Water-soluble steroid compounds |
SE8305864D0 (sv) * | 1983-10-25 | 1983-10-25 | L E Medical | Ogondroppar |
US4617299A (en) * | 1983-12-19 | 1986-10-14 | Knepper Paul A | Method for the prevention of ocular hypertension, treatment of glaucoma and treatment of ocular hypertension |
US4877774A (en) * | 1987-09-09 | 1989-10-31 | The United States Of America As Represented By The Department Of Health And Human Services | Administration of steroid hormones |
US5002935A (en) * | 1987-12-30 | 1991-03-26 | University Of Florida | Improvements in redox systems for brain-targeted drug delivery |
IE62095B1 (en) * | 1988-03-29 | 1994-12-14 | Univ Florida | Pharmaceutical formulations for parenteral use |
US5376645A (en) * | 1990-01-23 | 1994-12-27 | University Of Kansas | Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof |
EP0547223B1 (de) * | 1990-08-31 | 1996-10-16 | Santen Pharmaceutical Co., Ltd. | Arznei gegen hornhautbeschädigungen |
DK0593520T3 (da) * | 1991-06-18 | 2000-04-03 | Theramex | Forbindelser med indhold af steroider og deres anvendelse til behandling af glaucom |
JP2531558B2 (ja) * | 1991-08-17 | 1996-09-04 | ルブキン、バージニア | ドライアイ症処置用の性ステロイド膏薬、同薬の調製法および適用法 |
CA2425841C (en) * | 1991-11-22 | 2006-01-10 | Alcon Laboratories, Inc. | Angiostatic steroids |
US6107289A (en) * | 1992-04-21 | 2000-08-22 | The Schepens Eye Research Institute, Inc. | Ocular therapy in keratoconjunctivitis sicca using topically applied androgens or TGF-β |
JPH08503951A (ja) * | 1992-12-02 | 1996-04-30 | インサイト・ビジョン・インコーポレイテッド | シクロデキストリンとポリマーを用いた薬剤供給系 |
US5494901A (en) * | 1993-01-05 | 1996-02-27 | Javitt; Jonathan C. | Topical compositions for the eye comprising a β-cyclodextrin derivative and a therapeutic agent |
US6142989A (en) * | 1993-05-03 | 2000-11-07 | O'donnell, Jr.; Francis E. | Apparatus and method for customized laser correction of refractive error |
US5556395A (en) * | 1993-05-07 | 1996-09-17 | Visx Incorporated | Method and system for laser treatment of refractive error using an offset image of a rotatable mask |
RU2135176C1 (ru) * | 1993-12-14 | 1999-08-27 | Эли Лилли Энд Компани | Водорастворенный комплекс включения соединений бензотиофена с водорастворимым циклодекстрином, способ его получения и фармацевтическая композиция |
US5521168A (en) | 1994-10-13 | 1996-05-28 | Alcon Laboratories, Inc. | Estrogen metabolites for lowering intraocular pressure |
JP4313435B2 (ja) * | 1995-07-24 | 2009-08-12 | トラスティーズ オブ ボストン ユニバーシティー | プレグネノロンサルフェート誘導体によるnmdaレセプター活性の抑制 |
JP2000514442A (ja) * | 1996-07-12 | 2000-10-31 | ノボ ノルディスク アクティーゼルスカブ | 眼内圧を下げるための2―フェニル―3―アゾイルベンゾチオフェン |
DK0930876T3 (da) * | 1996-07-22 | 2005-02-14 | Renovo Ltd | Anvendelse af forbindelser, der fremmer estrogen aktivitet, til behandling af sår |
AUPO427196A0 (en) * | 1996-12-19 | 1997-01-23 | University Of Sydney, The | A method for preventing or controlling cataract |
AU754380B2 (en) * | 1998-03-12 | 2002-11-14 | Genentech Inc. | Method of preventing the death of retinal neurons and treating ocular diseases |
EP1142585A4 (de) * | 1999-01-12 | 2005-08-03 | Santen Pharmaceutical Co Ltd | Arznei gegen krankheiten der cornea |
US20010041745A1 (en) * | 1999-04-08 | 2001-11-15 | Bryant Henry Uhlman | Methods for increasing levels of acetylcholine |
MXPA01012769A (es) * | 1999-06-11 | 2003-06-24 | Watson Pharmaceuticals Inc | Administracion de esteroides androgenicos no orales para mujeres. |
WO2001041757A1 (fr) * | 1999-12-10 | 2001-06-14 | Senju Pharmaceutical Co., Ltd. | Composition pharmaceutique contenant de la cyclodextrine |
EP1177787A3 (de) * | 2000-07-28 | 2003-09-10 | Pfizer Products Inc. | Verwendung von einem Östrogen Agonist/Antagonist zur Behandlung von Katarakt |
US6605640B2 (en) * | 2001-01-31 | 2003-08-12 | Gerard M. Nolan | Method of treating certain eye diseases |
WO2002040032A2 (en) | 2000-11-17 | 2002-05-23 | Washington University | Cytoprotective estrogen derivatives |
US20040102438A1 (en) * | 2001-02-13 | 2004-05-27 | Brueckner Christopher | Gaba-receptor modulators for the treatment of neurodegenerative diseases of the eye |
TWI320712B (en) * | 2001-09-05 | 2010-02-21 | Alcon Inc | The use of non-feminizing estrogens as retinoprotective agents for the treatment of glaucoma |
EP1621199B8 (de) * | 2003-04-18 | 2011-01-19 | Advanced Medicine Research Institute | Mittel zur behanldung von krankheiten zur aufbringung auf das auge |
-
2004
- 2004-04-16 EP EP04727990A patent/EP1621199B8/de not_active Expired - Lifetime
- 2004-04-16 EP EP10182409A patent/EP2289488A3/de not_active Withdrawn
- 2004-04-16 EP EP10178007A patent/EP2311465A1/de not_active Withdrawn
- 2004-04-16 CA CA002527175A patent/CA2527175A1/en not_active Abandoned
- 2004-04-16 AT AT04727990T patent/ATE488240T1/de not_active IP Right Cessation
- 2004-04-16 EP EP10182452A patent/EP2301549A1/de not_active Withdrawn
- 2004-04-16 AU AU2004229291A patent/AU2004229291A1/en not_active Abandoned
- 2004-04-16 EP EP10177962A patent/EP2292239A3/de not_active Withdrawn
- 2004-04-16 DE DE602004030103T patent/DE602004030103D1/de not_active Expired - Lifetime
- 2004-04-16 WO PCT/JP2004/005479 patent/WO2004091630A1/ja active Application Filing
- 2004-04-16 EP EP10182380A patent/EP2305308A1/de not_active Withdrawn
- 2004-04-16 JP JP2005505476A patent/JP4564920B2/ja not_active Expired - Fee Related
-
2010
- 2010-04-23 JP JP2010099820A patent/JP2010184927A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
AU2004229291A1 (en) | 2004-10-28 |
JP4564920B2 (ja) | 2010-10-20 |
EP2289488A3 (de) | 2011-03-30 |
DE602004030103D1 (de) | 2010-12-30 |
CA2527175A1 (en) | 2004-10-28 |
EP2289488A2 (de) | 2011-03-02 |
EP1621199B1 (de) | 2010-11-17 |
EP1621199A1 (de) | 2006-02-01 |
EP1621199A4 (de) | 2006-09-27 |
WO2004091630A8 (ja) | 2005-11-24 |
EP2292239A3 (de) | 2011-03-30 |
WO2004091630A1 (ja) | 2004-10-28 |
EP2311465A1 (de) | 2011-04-20 |
JPWO2004091630A1 (ja) | 2006-08-17 |
EP2301549A1 (de) | 2011-03-30 |
EP2292239A2 (de) | 2011-03-09 |
EP1621199B8 (de) | 2011-01-19 |
EP2305308A1 (de) | 2011-04-06 |
JP2010184927A (ja) | 2010-08-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE488240T1 (de) | Mittel zur behanldung von krankheiten zur aufbringung auf das auge | |
PT1100516E (pt) | Extratos de matricaria (tanacetum parthenium) contra doencas inflamatorias | |
MXPA06013121A (es) | Metodo y composicion para el tratamiento de rinitis. | |
BR0308928A (pt) | Uso de toxina botulìnica para o tratamento de doenças cardiovasculares, bem como composição para uso em um procedimento cardiovascular | |
WO2006039231A3 (en) | Topical formulations for the treatment of depression with s adenosyl methionine | |
EA200970154A1 (ru) | Косметические или дерматологические препараты, содержащие n-ацетилцистеин | |
BRPI0417932A (pt) | lipólise medicamentosa de acúmulo de gordura | |
NO20061236L (no) | Farmasoytiske sammensetninger og fremgangsmater omfattende kombinasjoner av 2-alkyliden-19-nor-vitamin D derivater og paratyroidhoziiton | |
HK1110768A1 (en) | 5,6,7-trihydroxyheptanoic acid and analogs for the treatment of ocular diseases and diseases associated with hyperproliferative and angiogenic responses | |
EA200700983A1 (ru) | Применение андрогенов для снижения вероятности приобретения или лечения старения кожи | |
ATE326947T1 (de) | Thixotropes nasenspray | |
AR030345A1 (es) | Metodo de tratamiento de desordenes relacionados con angiogenesis | |
AR043252A1 (es) | Formulaciones de glucocorticoesteroides para tratar angiogenia ocular patologica | |
ATE344662T1 (de) | Mittel enthaltend n-chlortaurin sowie dessen verwendung zur behandlung von schleimhautpolypen | |
DK1596879T3 (da) | Anvendelse af kahalalidforbindelser til fremstilling af et medikament til behandling af psoriasis | |
DE602006005637D1 (de) | Entpigmentisierende bzw. aufhellende kosmetikzusammensetzung, die mindestens ein oxazolin als wirkstoff umfasst | |
AR015761A1 (es) | Un derivado del acido 2-metilpropionico,una composicion farmaceutica que lo incluye, uso de un derivado del acido 2-metilpropionico y un procedimiento parala fabricacion de una composicion farmaceutica para la prevencion o el tratamiento de enfermedades | |
HN2002000041A (es) | Pseudomicinas utilizadas contra enfermedades en plantas | |
WO2006076119A3 (en) | Treatment of skin diseases | |
KR20200089899A (ko) | 탈부착이 쉬운 방수메디밴드 | |
WO2005105106A3 (en) | Hormone treatment of macular degeneration | |
PE122099A1 (es) | Budesonida sola o en combinacion con acido ursodesoxicolico en la terapia de enfermedades colestasicas del higado | |
BR0202358A (pt) | Gel para tratamento de estrias | |
DOP2001000141A (es) | Proteina actuando como un modulador angiogenico | |
UA6873U (en) | Method for treating psoriasis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |